ZFIN ID: ZDB-PUB-080209-2
Zebrafish in hematology: sushi or science?
Carradice, D., and Lieschke, G.J.
Date: 2008
Source: Blood   111(7): 3331-3342 (Review)
Registered Authors: Carradice, Duncan, Lieschke, Graham J.
Keywords: none
MeSH Terms:
  • Animals
  • Biomedical Research/history
  • Biomedical Research/trends
  • Disease Models, Animal
  • Drug Delivery Systems
  • Genetic Diseases, Inborn/drug therapy
  • Genetic Diseases, Inborn/genetics
  • Genetic Diseases, Inborn/history
  • Genetic Diseases, Inborn/metabolism
  • Genetic Diseases, Inborn/pathology
  • Hematologic Diseases/drug therapy
  • Hematologic Diseases/genetics*
  • Hematologic Diseases/history
  • Hematologic Diseases/metabolism*
  • Hematologic Diseases/pathology
  • Hematology/history
  • Hematology/trends
  • Hematopoiesis/genetics*
  • History, 20th Century
  • History, 21st Century
  • Host-Pathogen Interactions/genetics
  • Humans
  • Inflammation/drug therapy
  • Inflammation/genetics
  • Inflammation/history
  • Inflammation/metabolism
  • Inflammation/pathology
  • Leukocytes/metabolism
  • Leukocytes/pathology
  • Zebrafish/genetics*
  • Zebrafish/metabolism*
PubMed: 18182572 Full text @ Blood
After a decade of the "modern era" of zebrafish in hematology research, what have been their major contributions to hematology and what challenges does the model face? This review argues that in hematology, zebrafish have demonstrated their suitability, are proving their utility, have supplied timely and novel discoveries, and are poised for further significant contributions. It presents an overview of the anatomy, physiology and genetics of zebrafish hematopoiesis underpinning their use in hematology research. While reverse genetic techniques enable functional studies of particular genes-of-interest, forward genetics remains zebrafish's particular strength. Mutants with diverse and interesting hematopoietic defects are emerging from multiple genetic screens. Some mutants model hereditary blood diseases, occasionally leading to disease genes first; others provide insights into developmental hematology. Models of malignant hematological disorders provide tools for drug-target and pharmaceutics discovery. Numerous transgenic zebrafish with fluorescently-marked blood cells enable live-cell imaging of inflammatory responses and host/pathogen interactions previously inaccessible to direct observation in vivo, revealing unexpected aspects of leukocyte behavior. Zebrafish disease models almost uniquely provide a basis for efficient whole animal chemical library screens for new therapeutics. Despite some limitations and challenges, their successes and discovery potential mean that zebrafish are here to stay in hematology research.